Fibromyalgia is also called as FMS. Fibromyalgia is a disorder classified by the presence of chronic widespread pain and tactile allodynia. The disorder is not directly life-threatening. While fibromyalgia is one of the most common diseases affecting the muscles, its cause is currently unknown. Fibromyalgia is a clinical syndrome defined by chronic widespread muscular pain, fatigue and tenderness. Fibromyalgia affects predominantly women (over 80 percent) between the ages of 35 and 55. The degree of symptoms may vary greatly from day to day with periods of flares. Fibromyalgia is a chronic condition characterized by widespread pain in your muscles, ligaments and tendons, as well as fatigue and multiple tender points places on your body where slight pressure causes pain.
Fibromyalgia is agreed upon as one thing'a disease entity or a painful entity. In fact, fibromyalgia really is a calamity. Tender points are places on the neck, shoulders, back, hips, arms or legs that hurt when touched. Every muscle in their body shouted out in pain. Treatment programs are most effective when they combine patient education, stress reduction, regular exercise, and medications. In addition, they felt devoid of energy as though someone had unplugged their power supply. The pain is biological, psychological, and social. It affects all parameters, including even a spiritual or religious component. Many medical conditions can cause pain in different areas of the body, mimicking fibromyalgia.
Cause of fibromyalgia Genetics Sleep disturbances Dopamine abnormality Changes in muscles metabolism Abnormal levels of Substance P in their spinal fluid Symptoms of Fibromyalgia abnormal sleep architecture heightened sensitivity fatigue sensitivity to noise and temperature mood changes musculoskeletal pain Environmental change physical problems memory problems anxiety and depressive irritable bowel syndrome Diagnosis for Fibromyalgia However, blood tests for TSH (thyroid stimulating hormone) and ESR (erythrocyte sedimentation rate) values can differentiate these diagnoses from fibromyalgia. The diagnosis of fibromyalgia is made purely on clinical grounds based on the doctor's history and physical examination.
Treatment for Fibromyalgia Medication, while important, is not the only treatment. Patient education, exercise, self-management skills and alternative therapies help treat fibromyalgia symptoms.
Low doses of sedating antidepressants (e.g. amitriptyline and trazodone) have been used to reduce the sleep disturbances that are associated with fibromyalgia. Considering nontraditional treatment options for your fibromyalgia pain. Some topical remedies ar used for the treatment of fibromyalgia. Current studies indicate the best pharmacologic treatment for treating pain (and improving disrupted sleep patterns) is low doses of tricyclic compounds including cyclobenzaprine and amitriptyline . Muscle relaxants, anti-epileptics (such as Neurontin and Lyrica) and other drug categories may be prescribed as well. Each issue of the Fibromyalgia Network Journal contains information about new treatment options, as well as advice about how to make use of existing medications to minimize fibromyalgia symptoms. Prevention for Fibromyalgia Schedule time to relax each day. Deep-breathing exercises and meditation will help reduce the stress that can bring on symptoms. Do exercise regularly. Stress reduction might include simple stress modification at home or work, biofeedback, relaxation tapes, psychological counseling, and/or support among family members, friends, and doctors.
These antibodies target substances such as IgE and neutralize it. Unlike conventional treatments such as corticosteroids that reverse inflammation after it has occurred, anti-IgE aims to curtail the inflammatory process before it starts. The results of the early trials of anti-IgE (rhuMAb-E25) are encouraging with no significant side effects reported to date. Anti-IgE should also be helpful in allergic rhinitis and possibly food allergies. New Medications New and modified asthma medications are likely to improve treatment of bronchial asthma. Several medications already in general use in Canada and Europe are to be marketed in the United States in the near future. Many other medications are being investigated. Anti-leukotrienesAdditional anti-leukotriene medications are likely to join montelukast ,zafirlukast, and zileuton, which are currently in use in the United States. An agent, MK-0591, which inhibits the action of an enzyme (5-lipoxygenase) involved in the formation of leukotrienes, has been found to be effective and appears promising. Verlukast and pranukast, two agents which block the action of leukotrienes after they are produced, also appear effective. Mediator Antagonists Asthma mediators are irritating chemicals that are either stored within allergy cells (mast cells, eosinophils) or produced when these cells are activated. These substances produce many changes that lead to inflammation of the bronchial tubes. Examples include histamine, leukotrienes, prostaglandins, cytokines, thromboxanes, and platelet-activating factor (PAF). Additional mediator antagonists which would have anti-inflammatory properties are currently under development. Two inhibitors of PAF (WEB-2086, L-659), have already been shown to reduce inflammation in bronchial asthma and appear promising.
Both Timothyjones & Ricky Hussey are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.
Timothyjones has sinced written about articles on various topics from ADHD, Acid Reflux and Beauty Tips. Timothy Jones writes articles for . He also writes for